Last reviewed · How we verify
NCT04746326
Treatment in Right Colon Diverticulitis Patients
NA trial testing Failure conservative treatment in Outcome in 26 participants. Completed in 20 January 2021.
1 January 2021
Quick facts
| Lead sponsor | Tepecik Training and Research Hospital |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | non randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 26 |
| Start date | 1 January 2020 |
| Primary completion | 1 January 2021 |
| Estimated completion | 20 January 2021 |
| Sites | 1 location across Turkey (Türkiye) |
Drugs / interventions tested
- Failure conservative treatment
- Surgery
- Conservative treatment — full drug profile →
Conditions studied
- Outcome — all drugs for Outcome →
Sponsor
Tepecik Training and Research Hospital
Who can join
Eligibility, any sex, with Outcome. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The right colon diverticula, unlike those in the left colon, contain all layers of the colon and is called the true diverticulum. Perforation is observed less frequently due to its full thickness. Conservative treatment can be applied unless complications such as abscess formation and free perforation occur. Unlike the left, right colon diverticulitis has low complications and can be treated conservatively. The differential diagnosis of right colon diverticulitis should be kept in mind in order to prevent unnecessary surgeries. Surgical treatment is inevitable in cases such as recurrent diverticulitis, generalized peritonitis, and suspected malignancy.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT04746326
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Outcome
Currently open trials in the same condition.
- NCT07013175 — Wise Choices in the Intensive Care Unit · NA · recruiting
- NCT06011187 — Assisted Fluid Management (AFM) System and Postoperative Outcome After High-risk Abdominal Surgery · NA · recruiting
- NCT06165081 — The Association Between Post-resuscitation Time Series Management in the Emergency Department and Short-term Outcomes fo · recruiting
- NCT06836687 — Effect of the New Definition of Epilepsies of the ILAE of 2014 on the Diagnosis After the First Seizure · recruiting
- NCT03893136 — The Registry Study of Takayasu Arteritis in East China · recruiting
Other Tepecik Training and Research Hospital trials
Trials by the same sponsor.
- NCT07533916 — ICU Environmental Noise and Healthcare Workers · completed
- NCT07526467 — Video-EEG Semiological Patterns in PNES · completed
- NCT07299708 — Effects of Sleep Quality, Anxiety, and Digital Behavior on Labor Progression in Term Primiparous Women: A Prospective Ob · completed
- NCT06563830 — Prevent Medical Device-Related Pressure Injury · NA · not yet recruiting
- NCT05946291 — Simulation Applications on the Level of Pressure Injury Knowledge and Evaluation · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04746326 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Tepecik Training and Research Hospital
- Last refreshed: 9 February 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04746326.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing